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Objective: To study the effect of emodin on protein and gene expressions of the mas-
sagers in mobility signal transduction system of cholecyst smooth muscle cells in guinea
pig with cholesterol calculus.
Methods: The guinea pigs were randomly divided into 4 groups, such as control group,
gall-stone (GS) group, emodin group and ursodeoxycholic acid (UA) group. Cholesterol
calculus models were induced in guinea pigs of GS, emodin and UA groups by lithogenic
diet, while emodin or UA were given to the corresponding group for 7 weeks. The
histomorphological and ultrastructure change of gallbladder were detected by microscope
and electron microscope, the content of plasma cholecystokinin (CCK) and [Ca2+]i were
analyzed successively by radioimmunoassay and ﬂow cytometry. The protein and mRNA
of Gsa, Gia and Cap in cholecyst cells were determined by western blotting and real time
polymerase chain reaction (RT-PCR).
Results: Emodin or UA can relieve pathogenic changes in epithelial cells and muscle
cells in gallbladder of guinea pig with cholesterol calculus by microscope and trans-
mission electron microscope. In the cholecyst cells of GS group, CCK levels in plasma
and [Ca2+]i decreased, the protein and mRNA of GS were down-regulated, the protein
and mRNA of Gi and Cap were up-regulated. Emodin signiﬁcantly decreased the
formative rate of gallstone, improved the pathogenic change in epithelial cells and muscle
cells, increased CCK levels in plasma and [Ca2+]i in cholecyst cells, enhanced the protein
and mRNA of Gs in cholecyst cells, reduced the protein and mRNA of Gi and Cap in
cholecyst cells in guinea pig with cholesterol calculus.
Conclusion: The dysfunction of gallbladder contraction gives rise to the disorders of
mobility signal transduction system in cholecyst smooth muscle cells, including low content
of plasmaCCKand [Ca2+]i in cholecyst cells, abnormal protein andmRNAofGs,Gi andCap.
Emodin can enhance the contractibility of gallbladder and alleviate cholestasis by regulating
plasma CCK levels, [Ca2+]i in cholecyst cells and the protein and mRNA of Gs, Gi and Cap.1. Introduction
Cholelithiasis represents a signiﬁcant burden on healthcare
systems throughout the world, affecting approximately 22.87% of
the Han Chinese [1]. Cholelithiasis is also an important public
health problem in some Asian countries including China, where
cholecystectomy was executed for 11.5% of all hospitalizations
between 1985 and 1995 [2–4]. Several mechanisms contribute to
gallbladder stone formation, including gallbladder hypo motility,
cholesterol super-saturation of bile, destabilization of bile by ki-
netic protein factors, and abnormal mucin products [2,5,6]. Among
them gallbladder motility disorders is more important forrticle under the CC BY-NC-ND license (http://
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smooth muscle movement [7,8]. Impaired muscle contraction and
relaxation in gallbladders may be due to an abnormal
cholecystokinin (CCK) receptor-binding capacity and a difﬁcult
signal-transduction cascade distal to the activation of G proteins
[9,10]. Themechanism for abnormalCCK receptor-binding capacity
gives rise to decreased membrane ﬂuidity, an excessive cholesterol
content and high cholesterol-to-phospholipid ratio, which may
affect the functions of G protein signal-transduction cascade,
including inhibitory adenylate cyclase G protein (Gi), stimulating
adenylate cyclaseG protein (Gs), secondmessengers inositol 1,4,5-
trisphosphate (IP3) and the enzyme Calponin (Cap) [11].
Emodin (1, 3, 8 – t r i h y d r o x y – 6 – m e t h y L -anthra-
quinone) is a biologically active natural anthraquinone extracted
from the roots and rhizomes of Rheum palmatum (Chinese name
DaHuang), which is one of the most effective traditional Chinese
medicines for constipation and has now been ofﬁcially listed in the
Chinese Pharmacopoeia [12]. Some possible mechanisms could be
involved in the emodin-induced smooth muscle contraction in the
gastrointestinal tract. Firstly, emodin enhances the function of
small intestinal peristalsis through inhibiting the secretion of so-
matostatin and triggering the release of motilin [13]. Secondly,
emodin directly contracts the colon smooth muscle by elevating
the intracellular Ca2+ concentration [14]. It has been reported that
emodin has been applied in cholesterol stones and cholecystitis
for enhancing the contraction of gallbladder smooth muscle [15].
However, the mechanisms have not been fully elucidated.
This study intends to explore the mechanism of emodin regu-
lating the motility of gallbladder signal transduction function and
improving the gallbladder contraction ability, including histologi-
cal analysis and of cholesterol gallstone in guinea pig, plasmaCCK
levels and [Ca2+]i concentration detection, Gs, Gi, Cap protein and
mRNA determination in the gallbladder smooth muscle cells.
2. Materials and methods
The antibodies of Gs, Gi, Cap, b-actin were purchased from
Abcam. Ursodeoxycholic acid (UDCA') was purchased from
Sanwei Pharmaceuticals (Shanghai, China). Benzyl sulphonic
acid ﬂuorine (PMSF) was from Shanghai Shengneng gaming
biological technology co., Ltd; Acrylamide was from Gibco;
Tris-base was from Boehringer; Emodin, sodium dodecyl sulfate
(SDS), protease inhibitor cocktail, glycine, ammonium persulfate,
DEPC and TEMED were from Sigma; Chemiluminescence
chromogenic reagent kit and protein assay kit were from (Thermo
Scientiﬁc). Hematoxylin and eosin were purchased from Sino-
pharm Chemical Reagent Co., Ltd. Cholecystokinin (CCK) ra-
diation immunity test kit was provided by the second military
medical university neurobiology teaching and research section.
2.1. Animals and grouping
White guinea pig with red eye [200–240 g/body weight, half
were male and half were female], were obtained from the Experi-
mental Animals Center of the Shanghai University of Traditional
Chinese Medicine (Shanghai, China). Guinea pigs maintained un-
der pathogen-free conditions at a room temperature of (23 ± 3) C
and air humidity of (55 ± 15)% in a 12 h light/12 h dark cycle.
A total of 60 guinea pigs were provided free access to water and
were divided into four groups (15 guinea pigs for each group)
according to their body weight: control group, gall-stone (GS)group, emodin group and ursodeoxycholic acid (UA) group.
Guinea pigs in GS group were fed by lithogenous diet containing
1% cholesterol, 0.5% cholic acid and 15% butter fat for 8 weeks.
For gallstone prevention studies, guinea pigs in emodin groupwere
given a lithogenic diet supplementedwith emodin (Sigma, USA) at
100 mg/kg every 12 h for 8 weeks. Those in UA group were
administered with a lithogenic diet supplemented with UA (80mg/
kg/d) (Shanghai Sanwei Pharmaceuticals, China, No.H31021950)
for 8 weeks [16]. The gallbladder samples were taken for detection
at the eighth weekend. The experimental protocols were approved
by the Committee of Animal Experimentation of the Shanghai
University of Traditional Chinese Medicine.
2.2. Histological analysis
Gallbladder specimens were ﬁxed in 10% buffered formalin,
processed by standard techniques and embedded in parafﬁn.
Cross-sectional cuts 3 mm thick were taken from the middle
zones of the gallbladder. The sections were stained with hema-
toxylin and eosin for histopathology, and examined with a light
microscope (Zeiss Axioscop 40, Zeiss) by a pathologist who was
blinded to the experimental groups. Ten high power ﬁelds were
observed (×200), and digital images were obtained with a digital
camera (Nikon 4500, Japan) and archived.
2.3. Electron microscopy
Obtain the gallbladder specimen fast. The gallbladder slices
were prepared for electron microscopy by ﬁxation, dehydration,
and embedment in araldite in situ. Portions of the embedment
containing suitable cells selected by light microscopy were cut
out and afﬁxed to a small metal dowel, sectioned in a Porter-
Blum microtome with glass knives, mounted on bare grids,
stained with 1.0% KMnO4, and studied in a Siemens Elmiskop I.
2.4. Radioimmunoassay
2 mL blood was obtained from guinea pig heart accurately
and injected into precooling, 20 mL 1% heparin anticoagulant.
Serum (100 mL was diluted with 400 mL of saline and extracted
twice with 2 mL of diethyl ether). The water phase was left
frozen in solid carbon dioxide bath and ether extracts were
combined and evaporated to dryness. The buffer or standard
solution, radio ligand and antiserum, 100 mL, each were added.
The tubes for unspeciﬁc binding determination contained radio
ligand and buffer ﬁnal volume in each tube was 300 mL The
content of tubes was mixed in vortex, and after overnight in-
cubation at 4 C, 500 mL of dextran coated charcoal (0.25 and
0.025 g/100 mL) was added to each tube. The content was
vortexed brieﬂy and after 10 min staying at 4 C, the tubes were
centrifuged at 4 C and 3000 rpm for 10 min. The supernatants
were decanted into another set of tubes in which the radioac-
tivity of 125I was measured on Berthold gamma counter. The
concentration of CCK was calculated from log–logit plot.
2.5. RNA extraction and real-time reverse transcription
(RT)-PCR analysis
Total RNA in gallbladder was isolated by using Trizol re-
agent (Invitrogen, USA) and reverse transcribed into cDNAs by
using a First-strand cDNA Synthesis kit (Roche Applied
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mation of Gi, Gs and CAP mRNA. The primers for Gi were
sense 50-CAGAGGATGCATTTTGAGCA-30 and antisense 50-
CAAAGCAGTTCTGACCACCA-30. The primers for Gs were
sense 50-AGAAGCAGCTGCAGAAGGAC-30 and antisense 50-
CCCTCTCCGTTAAACCCATT-30. The primers for CAP were
sense 50- ACTTCATGGATGGCCTCAAG-30 and antisense 50-
GTGCCAGTTCTGGGTTGACT-30. Real-time-PCR was per-
formed in a total volume of 10 mL per reaction. We placed 1 mL
of cDNA into a 9-mL reaction mixture that contained 0.1 mL of
Taq DNA polymerase, 1 mL of the supplied 10× PCR buffer,
0.5 mL of MgCl2 (50 mmol/L), 0.2 mL of dNTPs (10 mmol/L),
0.15 mL of bovine serum albumin (10 g/L), 0.5 mL of the
appropriate sense primer, 0.5 mL of the corresponding antisense
primer (3 mmol/L) and 1 mL of the TaqMan probe (3 mmol/L).
DEPC–H2O was added to a ﬁnal volume of 10 mL. The cycling
protocol consisted of an initial 5-min denaturation step at 88 C,
followed by 50 cycles of denaturation at 94 C for 10 s,
annealing at 55 C for 20 s, and extension at 72 C for 20 s. The
PCR products were subjected to electrophoresis in 2% agarose
gels, stained with ethidium bromide, and visualized under UV
light. The expression of aˆ-actin mRNA was ampliﬁed in parallel
as control for RNA loading and RT-PCR efﬁciency.
2.6. Western blot analysis
The gallbladder proteins were homogenized in PBS with
protease inhibitor cocktail. The homogenates were centrifuged for
15 min at 14000 rpm in 4 C. Supernatants of the tissues were
collected and protein concentration was measured with a bicin-
choninic acid assay kit. An equal amount of protein from each
sample (150 mg) was resolved in 10% Tris-glycine SDS poly-
acrylamide gel. Protein bands were blotted to nitrocellulose
membranes. After incubation for 1 h in blocking solution at room
temperature, the membrane was incubated for 24 h with anti-Gia´
antibodies, anti-Gsa´ antibodies or anti-CAP antibody at 4 C,
respectively. The secondary antibody (horseradish peroxidase-Figure 1. Histological change of gallbladder in different groups (HE × 200).
A. Control group. B. GS group. C. Emodin group. D. UA group.conjugated goat anti-rabbit immunoglobulin) was added and
incubated at room temperature for 1 h. Peroxidase labeling was
detected with the Western blotting detection system and analyzed
by a densitometry system. The relative protein levels of Gia´, anti-
Gsa´ or CAP were normalized to aˆ-actin.
2.7. Flow cytometry
The gallbladder of guinea pigs were cut into pieces and washed
by PBS repeatedly. The cell suspension was obtained with 40 mm
nylon mesh ﬁltration, washed by PBS twice and centrifuged at
1500 rpm for 5min. After the supernatant was discarded, each tube
was regulated to possess 106 cells and mixed ﬂuo-3 markers for
[Ca2+] detection on a FACS calibur ﬂow cytometer. Green ﬂuo-
rescence emission of Fluo-3 was detected at 530 nm and the per-
centages of ﬂuo-3− cells were quantiﬁed with Cell Quest software.
2.8. Statistical analysis
Data are presented as mean ± SE. The signiﬁcance of the
difference in mean values within and among multiple groups
was examined with an ANOVA for repeated measures followed
by a Duncan's post hoc test. Student's t-test was used to evaluate
the signiﬁcance of differences between two groups of experi-
ments (SigmaStat, SPSS). A value of P < 0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Emodin can relieve the inﬂammation of the
gallbladder
There were crystal deposits attached with the gallbladder
epithelial cells and full of gallbladder by microscope in GS
group compared with control group. In the GS group lots of
gallbladder epithelial cells disappeared, gallbladder cavity was
Figure 2. Change of gallbladder epithelial cells in different groups under TEM.
A. Control group (TEM × 7500) B. GS group (TEM × 10000) C. emodin group. (TEM × 13000) D. UA group. (TEM × 13000).
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mucosa layer were inﬁltrated with inﬂammatory cells and
showed edema and hemorrhage (Figure 1A, B). In the emodin
group gallbladder epithelial cells showed intact, mild hyperemia
and edema appeared in the submucosa. In the ursodeoxycholic
acid (UA) group the epithelial cells of gallbladder tissue bears
the basic integrity, mild dilatation and hyperemia appeared in the
sub-mucosal vessels (Figure 1C, D).
Under transmission electron microscope, the dense deposits,
few microvilli, swelling endoplasmic reticulum, expanded
Golgi, irregular mitochondria, nuclear membrane shrinkage and
adhesion fusion appeared in the guinea pig gallbladder epithelial
cells of GS group (Figure 2A, B). Different from GS group, the
gallbladder epithelial cells of emodin group and UA group were
similar with those of control group (Figure 2C, D).
3.2. Emodin increase plasma CCK levels in the guinea
pig with cholesterol gallstone
Radioimmunoassay showed that the plasma CCK level of GS
group (63.63 ± 9.14, pmol/L) was lower than the control groupFigure 3. Plasma CCK levels in the guinea pig of different groups.
*P< 0.05 compared with control group; #P< 0.05 compared with GS group.(138.91 ± 14.64, pmol/L) (P < 0.01). The plasma CCK level of
emodin group (102.37 ± 10.19, pmol/L) or UA group
(104.65 ± 11.13, pmol/L) was higher than the control group
(138.91 ± 14.64, pmol/L) (P < 0.01), but still was lower than the
control group (P < 0.01) (Figure 3).Figure 4. Effect of emodin on Gsa´ mRNA and protein in gallstone gall-
bladder.
A. Change of Gs protein in gallstone gallbladder in different groups by
Western blot analysis. B. Change of Gs mRNA in gallstone gallbladder in
different groups by RT-PCR analysis vs. *P < 0.05 compared with control
group; #P < 0.05 compared with GS group.
Figure 6. Change of emodin on [Ca2+]i concentration in different groups.
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gallstone gallbladder
Western blot analysis demonstrated that Gs alpha protein of the
gallbladder in the GS group was lower than that of control group
(P< 0.01). Compared with GS group, Gs alpha protein production
of the gallbladder from emodin group or UA group obviously
exceeded. Especially, Gs alpha protein of the gallbladder from
emodin group had a little less production than that of UA group
(Figure 4A). Gs alphamRNAof the gallbladder had similar change
with Gs alpha protein by RT-PCR analysis (Figure 4B).
3.4. Effect of emodin on Gia´ mRNA and protein in
gallstone gallbladder
Western blot analysis demonstrated that Gi alpha protein of the
gallbladder in the GS group was lower than that of control group
(P< 0.01). Comparedwith GS group, Gi alpha protein production
of the gallbladder from emodin group or UA group obviously
elevated. Especially, Gi alpha protein of the gallbladder from
emodin group had lesser production than that of UA group
(Figure 5A). RT-PCR analysis demonstrated that Gi alpha mRNA
changed similarly with Gi alpha protein (Figure 5B).Figure 5. Effect of emodin on Gi mRNA and protein in gallstone gall-
bladder.
A. Change of Gi protein in gallstone gallbladder in different groups by
Western blot analysis. B. Change of Gi mRNA in gallstone gallbladder in
different groups by RT-PCR analysis. *P < 0.05 compared with control
group; #P < 0.05 compared with GS group.3.5. Effect of emodin on Ca2+ concentration and cap in
gallbladder cells of the guinea pig with cholesterol
calculus
Flow cytometry experiments showed that the [Ca2+]i con-
centration in gallbladder cells of GC group was lower (P < 0.01)
compared with control group. Both emodin and UA can increase
[Ca2+]i concentration in gallbladder cells compared with GC
group (P < 0.01) (Figure 6). As calcium binding protein, Cap
protein of the gallbladder in the GS group was higher than that
of control group according to Western blot analysis (P < 0.01).
Compared with GS group, Cap protein production of the gall-
bladder from emodin group or UA group obviously descended.
Especially, Cap protein of the gallbladder from emodin group
had lesser production than that of UA group (P > 0.05)
(Figure 7A). RT-PCR analysis demonstrated that Cap mRNA of
the gallbladder had similar change with Cap protein (Figure 7B).Figure 7. Effect of emodin on Cap mRNA and protein in gallstone gall-
bladder.
*P < 0.05 compared with control group; #P < 0.05 compared with GS
group.
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The injury of gallbladder epithelial cells and abnormality of
smoothmuscle movement initiated gallbladder motility disorders.
In China, rhubarb has been applied in the treatment of cholesterol
stones for hundreds of years. As main effective ingredient of
rhubarb, emodin has been demonstrated that emodin increased the
resting tension of gallbladder smooth muscle strips in a dose-
dependent manner [17]. In the present study, we found that both
emodin and UA relieved injury of epithelial cells in gallbladder
of guinea pig with cholesterol calculus.
CCK is a gastrointestinal hormone that is produced and
secreted by intestinal cells. It has been found that plasma con-
centrations of CCK signiﬁcantly increased after ingestion, which
can promote a signiﬁcant contraction of the gallbladder [18].
Lack of CCK induces gallbladder hypomotility that prolongs
the residence time of excess cholesterol in the gallbladder,
leading to rapid crystallization and precipitation of solid
cholesterol crystals [19]. CCK interacts with CCK receptor-A
(CCK-R) in gallbladder, which elicits the contraction of gall-
bladder by the activation of post-membrane signaling passage in
smooth muscle [20]. The results of this study showed that emodin
made a signiﬁcant increase in plasma concentrations of CCK
and raised gallbladder motility in guinea pig with
cholelithiasis. Combined with Flow cytometry experiments
showed that the [Ca2+]i concentration impaired muscle
contraction and relaxation in gallbladders may be due to an
abnormal CCK receptor-binding capacity and a difﬁcult
signal-transduction cascade distal to the activation of G proteins
[9,10]. The mechanism for abnormal CCK receptor-binding ca-
pacity gives rise to decreased membrane ﬂuidity, an excessive
cholesterol content and high cholesterol-to-phospholipid ratio,
which may affect the functions of G protein signal-transduction
cascade, including inhibitory adenylate cyclase G protein (Gi),
stimulating adenylate cyclase G protein (Gs), second messengers
inositol 1,4,5-trisphosphate (IP3) and the enzyme Calponin
(Cap) [11]. Calponin is a calcium binding protein. Calponin
tonically inhibits the ATPase activity of myosin in smooth
muscle. Phosphorylation of calponin by a protein kinase,
which is dependent upon calcium binding to calmodulin,
releases the calponin's inhibition of the smooth muscle
ATPase. In the cholecyst cells of GS group, CCK levels in
plasma and [Ca2+]i decreased, the protein and mRNA of Gs
were down-regulated, the protein and mRNA of Gi and Cap
were up-regulated. Emodin signiﬁcantly decreased the formative
rate of gallstone, improved the pathogenic change in epithelial
cells and muscle cells, increased CCK levels in plasma and
[Ca2+]i in cholecyst cells, enhanced the protein and mRNA of Gs
in cholecyst cells, reduced the protein and mRNA of Gi and Cap
in cholecyst cells in guinea pig with cholesterol calculus.
The dysfunction of gallbladder contraction gives rise to the
disorders of mobility signal transduction system in cholecyst
smooth muscle cells, including low content of plasma CCK and
[Ca2+]i in cholecyst cells, abnormal protein and mRNA of Gs, Gi
and Cap. Emodin can enhance the contractibility of gallbladder
and alleviate cholestasis by regulating plasma CCK levels, [Ca2+]i
in cholecyst cells and the protein and mRNA of Gs, Gi and Cap.
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